Women less likely to die after TAVI than men
2013-09-02
Dr Sherif said: "Earlier studies on the impact of gender on outcome after transcatheter aortic valve implantation (TAVI) have had conflicting results. A Canadian study reported in 641 consecutive patients that female sex is associated with a better long-term and short-term survival after TAVI.1 An Italian study of 305 high risk patients found no gender differences in composite safety and efficacy endpoints at 30 days and one year after TAVI."2
The current analysis examined gender differences in outcomes for 1432 consecutive patients from 27 centers who were enrolled in ...
TAVI feasible in bicuspid aortic valve
2013-09-02
Bicuspid aortic valve (BV) is the most common congenital valvular abnormality, occurring in 1-2% of the general population. Two of the aortic valvular leaflets fuse during development resulting in a valve that is bicuspid instead of the normal tricuspid configuration. BV is associated with increased mechanical stress which predisposes to calcification and development of aortic stenosis which narrows the opening of the aortic valve.
Dr Bauer said: "TAVI is used to treat elderly high risk patients with severe aortic stenosis. Despite previous assumptions the frequency of ...
Health of older women in developed countries continues to improve
2013-09-02
Measures taken in developed countries to reduce noncommunicable diseases – the leading causes of death globally – have improved the life expectancy of women aged 50 years and older over the last 20 to 30 years. But, according to a study that will be published in the Bulletin of the World Health Organization on 2 September, the gap in life expectancy between such women in rich and poor countries is growing.
The WHO study, one of a collection of articles in a special issue of the journal devoted to women's health beyond reproduction, found that the leading causes of death ...
Stomach bacteria switch off human immune defences to cause disease
2013-09-02
Helicobacter pylori is a bacterium that establishes a life-long stomach infection in humans, which in some cases can lead to duodenal ulcers or stomach cancer. New research, presented at this week's Society for General Microbiology Autumn Conference, gives us a clearer understanding of how these bacteria can manipulate the human immune system to survive in the mucosal lining of the stomach.
Researchers from the University of Nottingham have shown that H. pylori is able to supress the body's normal production of 'human beta defensin 1' (hβD1), an antimicrobial factor ...
Scientists discover novel functions of platelets
2013-09-02
OKLAHOMA CITY, September 1, 2013 — A new finding could lead to novel treatments to reduce bleeding in trauma and severe infections.
The research, from Oklahoma Medical Research Foundation scientists Lijun Xia, M.D., Ph.D., Jianxin Fu, M.D., Ph.D., and Brett Herzog, Ph.D., appears in the most recent issue of the journal Nature.
One way the immune system keeps a body healthy is through immune surveillance. Lymphocytes, a type of white blood cell, constantly exit the bloodstream and "check in" at the lymph nodes to learn about possible pathogens or abnormal cell growth. ...
Spread of crop pests threatens global food security as Earth warms
2013-09-02
A new study has revealed that global warming is resulting in the spread of crop pests towards the North and South Poles at a rate of nearly 3 km a year. The study, published in the journal Nature Climate Change and carried out by researchers at the University of Exeter and the University of Oxford, shows a strong relationship between increased global temperatures over the past 50 years and expansion in the range of crop pests.
Currently 10-16% of global crop production is lost to pests. Crop pests include fungi, bacteria, viruses, insects, nematodes, viroids and oomycetes. ...
Researchers untangle genetics of drug resistant TB
2013-09-02
For years, physicians around the world have watched as strain after strain of the deadly bacteria Mycobacterium tuberculosis evolves resistance to drugs.
Over the last few decades researchers have used the tools of molecular biology to identify a handful of individual mutations that allow TB to withstand many of the key therapeutics that doctors use to treat it. These genetic markers serve as clues for new drug development and as tools for diagnosing drug-resistant strains of TB. But the pace of discovery has proven too slow in the face of the complex array of rapidly ...
Mycobacterium tuberculosis: Our African follower for over 70,000 years!
2013-09-02
Tuberculosis (TB) remains one of deadliest infectious diseases of humans, killing 50% of individuals when left untreated. Even today, TB causes 1-2 million deaths every year mainly in developing countries. Multidrug-resistance is a growing threat in the fight against the disease.
An international group of researchers led by Sebastien Gagneux from the Swiss Tropical and Public Health Institute (Swiss TPH) has now identified the origin in time and space of the disease. Using whole-genome sequencing of 259 Mycobacterium tuberculosis strains collected from different parts ...
DNA 'cages' may aid drug delivery
2013-09-02
Nanoscale "cages" made from strands of DNA can encapsulate small-molecule drugs and release them in response to a specific stimulus, McGill University researchers report in a new study.
The research, published online Sept. 1 in Nature Chemistry, marks a step toward the use of biological nanostructures to deliver drugs to diseased cells in patients. The findings could also open up new possibilities for designing DNA-based nanomaterials.
"This research is important for drug delivery, but also for fundamental structural biology and nanotechnology," says McGill Chemistry ...
Breakthrough in sensing at the nanoscale
2013-09-02
Researchers have made a breakthrough discovery in identifying the world's most sensitive nanoparticle and measuring it from a distance using light. These super-bright, photostable and background-free nanocrystals enable a new approach to highly advanced sensing technologies using optical fibres.
This discovery, by a team of researchers from Macquarie University, the University of Adelaide, and Peking University, opens the way for rapid localisation and measurement of cells within a living environment at the nanoscale, such as the changes to a single living cell in the ...
Increased greenhouse gases and aerosols have similar effects on rainfall
2013-09-02
Although greenhouse gases and aerosols have very distinct properties, their effects on spatial patterns of rainfall change are surprisingly similar, according to new research from the University of Hawaii at Manoa's International Pacific Research Center (IPRC) and Scripps Institution of Oceanography. The study is published in the September 1 online issue of Nature Geoscience.
Manmade climate change comes mostly from the radiative forcing of greenhouse gases and air pollutants or aerosols. While greenhouse gases are well-mixed in the atmosphere and tend to be evenly distributed ...
New data reveals that the average height of European males has grown by 11cm in just over a century
2013-09-02
The average height of European males increased by an unprecedented 11cm between the mid-nineteenth century and 1980, according to a new paper published online today in the journal Oxford Economic Papers. Contrary to expectations, the study also reveals that average height actually accelerated in the period spanning the two World Wars and the Great Depression.
Timothy J. Hatton, Professor of Economics at the University of Essex and the Research School of Economics at Australian National University in Canberra, examined and analysed a new dataset for the average height ...
World-leading penguin experts come to Britain
2013-09-02
Research: New research has revealed how the Emperor Penguin is able to dive to depths of over 500m and stay under water for up to 27 minutes – deeper and longer than any of its fellow avian species.
Researchers from the University of California will be presenting their new findings at the International Penguin Conference (IPC) which begins in Bristol today [02 September].
It's the first time the conference has been held in Europe, with 200 delegates from 30 countries sharing their latest research and knowledge at the University of Bristol and Bristol Zoo Gardens between ...
Droplet Digital PCR enables reproducible quantification of microRNA biomarkers
2013-09-02
Seattle, Wash. — September 1, 2013 — A study published online in Nature Methods today demonstrated that Droplet Digital PCR (ddPCR™) technology can be used to precisely and reproducibly quantify microRNA (miRNA) in plasma and serum across different days, paving the way for further development of miRNA and other nucleic acids as circulating biomarkers.
"In the field of circulating microRNA diagnostics, droplet digital PCR enables us to finally perform biomarker studies in which the measurements are directly comparable across days within a laboratory and even among different ...
Stanford scientists show how antibiotics enable pathogenic gut infections
2013-09-02
STANFORD, Calif. — A new study by researchers at the Stanford University School of Medicine could help pinpoint ways to counter the effects of the antibiotics-driven depletion of friendly, gut-dwelling bacteria.
A number of intestinal pathogens can cause problems after antibiotic administration, said Justin Sonnenburg, PhD, assistant professor of microbiology and immunology and the senior author of the study, to be published online Sept. 1 in Nature. Graduate students Katharine Ng and Jessica Ferreyra shared lead authorship.
"Antibiotics open the door for these pathogens ...
Scientists sequence genome of high-value grape, seek secrets of wine's aroma
2013-09-02
Demystifying the chemical processes that create a wine's aroma, and the invaluable potential application of that understanding in winemaking, is the new objective of scientists in Uruguay who, with European partners, also recently sequenced the genome of the high-value Tannat grape, from which "the most healthy of red wines" are fermented.
Meanwhile, a quick, $1 test in development by researchers in Paraguay and Uruguay promises to reduce the economic and health burden of 3 million cases of syphilis in Latin America -- a disease readily treated and cured if diagnosed ...
Drug reduces hospitalizations and cost of treating young children with sickle cell anemia
2013-09-02
A drug proven effective for treatment of adults and children with sickle cell anemia reduced hospitalizations and cut annual estimated medical costs by 21 percent for affected infants and toddlers, according to an analysis led by St. Jude Children's Research Hospital. The report appears today in the advance online edition of the journal Pediatrics.
The study is the largest ever focusing on the economic impact of the drug hydroxyurea in children with the inherited blood disorder. The result supports expanded use of the drug to extend the length and quality of life for ...
Risk factors for cardiovascular problems found to be inverse to disease and deaths
2013-09-02
Hamilton, ON (September 2, 2013) – Despite living with the highest risk factors for heart disease, people in high income countries suffer less from serious cardiovascular disease, says an international study by the global PURE (Prospective Urban Rural Epidemiology ) collaboration and led by McMaster University researchers.
At the same time, the study found that people in low income countries, although living with fewer risk factors for heart disease, have a higher incidence of serious cardiovascular disease including death.
"These findings were a total surprise," ...
Metabolically healthy women have same CVD risk regardless of BMI
2013-09-02
Amsterdam, The Netherlands – Monday 2 September 2013: Metabolically healthy women have the same cardiovascular disease risk regardless of their BMI, according to research presented at the ESC Congress today by Dr Søren Skøtt Andersen and Dr Michelle Schmiegelow from Denmark. The findings in more than 260,000 subjects suggest that obese women have a window of opportunity to lose weight and avoid developing a metabolic disorder, which would increase their CVD risk.
Dr Schmiegelow said: "Obesity and/or metabolic disorders (hypertensive disorders [hypertension, gestational ...
Pacemaker for slow heart rhythm restores life expectancy
2013-09-02
Amsterdam, The Netherlands – Monday 2 September 2013 : Pacemakers implanted for slow heart rhythm restore life expectancy to normal levels, reveals research presented at ESC Congress 2013 today by Dr Erik O. Udo from the Netherlands. The findings provide a new reference point for the prognosis of modern pacemaker patients.
Dr Udo said: "Previous studies describing the survival of pacemaker patients used data that is more than 20 years old and cannot be used anymore for patient counselling and benchmarking. There have been considerable changes in pacemaker technology ...
ASSURE study of experimental agent to raise HDL yields 'disappointing and surprising' results
2013-09-02
AMSTERDAM, The Netherlands, 2 September2013 – The search continues for an agent that increases high-density lipoprotein (HDL) and reduces arterial plaque, after the experimental apolipoprotein A1 (apoA1) inducer, RVX-208 failed to do so in the ApoA1 Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation (ASSURE) study.
The lack of efficacy of RVX-208 is "disappointing and surprising, given promising earlier findings," noted lead investigator Stephen Nicholls MBBS, PhD, Deputy Director at the South Australian Health and Medical Research ...
Common blood pressure drug reduces aortic enlargement in Marfan syndrome
2013-09-02
AMSTERDAM, The Netherlands - A common drug that is used to treat high blood pressure in the general population has been found to significantly reduce a dangerous and frequently fatal cardiac problem in patients with Marfan syndrome.
Results of the COMPARE (COzaar in Marfan PAtients Reduces aortic Enlargement) study reveal that patients treated with losartan (Cozaar) had a significantly reduced rate of aortic enlargement after 3 years compared to patients who did not receive the treatment.
"Our study is the first large, prospective randomized study to assess the effects ...
Treatment with the anti-diabetic drug alogliptin does not increase CV risk in patients with ACS
2013-09-02
AMSTERDAM, The Netherlands – Patients with type 2 diabetes and high cardiovascular risk due to recent acute coronary syndromes had similar rates of cardiovascular events when treated with the anti-diabetic agent alogliptin compared to placebo according to results of the Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care (EXAMINE) trial presented at the European Society of Cardiology Congress.
"Compared with placebo, treatment with alogliptin resulted in similar rates of the primary endpoint, which was a composite of cardiovascular death, myocardial ...
Move it and lose it: Every 'brisk' minute counts
2013-09-01
To win the war against weight gain, it turns out that every skirmish matters – as long as the physical activity puts your heart and lungs to work.
In a new study published today in the American Journal of Health Promotion, University of Utah researchers found that even brief episodes of physical activity that exceed a certain level of intensity can have as positive an effect on weight as does the current recommendation of 10 or more minutes at a time.
"What we learned is that for preventing weight gain, the intensity of the activity matters more than duration," says ...
Anticoagulant does not reduce rate of ischemic events among certain patients undergoing PCI
2013-09-01
Use of the novel anticoagulant otamixaban did not reduce ischemic events compared with unfractionated heparin plus eptifibatide but increased bleeding among patients with non–ST-segment elevation acute coronary syndromes undergoing a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a study published by JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology Congress 2013
"Major progress has been made in ...
[1] ... [3758]
[3759]
[3760]
[3761]
[3762]
[3763]
[3764]
[3765]
3766
[3767]
[3768]
[3769]
[3770]
[3771]
[3772]
[3773]
[3774]
... [8225]
Press-News.org - Free Press Release Distribution service.